News
GSK Sales, Core Earnings Expected to Edge Lower -- Earnings Preview
SALES FORECAST: The U.K. pharmaceutical company is expected to report sales of 7.8 billion pounds ($10.42 billion), according to consensus estimates compiled by the company. For last year's second quarter, GSK reported sales of 7.88 billion pounds.
GSK Plc reported better-than-expected profit and raised its estimates for revenue at two key divisions in a report that ...
British pharmaceutical giant GSK Plc (NYSE:GSK) shares rose on Wednesday after reporting second-quarter results that ...
GSK ( NYSE: GSK) CEO Emma Walmsley said on Wednesday that her company is in discussions with the Trump administration on how ...
British drugmaker GSK said on Wednesday it is in talks with the Trump administration about ways to lower U.S. drug costs, ...
UK-based big pharma GlaxoSmithKline (GSK) has released its Q2 2025 results, which highlight the varying successes of its ...
CEO Emma Walmsley maintained that continued investment in the U.S. is a priority for the pharma to ensure its medicines for ...
Its second-quarter sales rose to 7.99 billion pounds from 7.88 billion pounds in the same period the year prior.
GSK’s cobolimab has become the latest anti-TIM-3 antibody to flunk a crucial oncology test, as the pharma absorbs a more than $600 million hit from its anti-TIGIT drug failure. | GSK’s cobolimab has ...
British pharmaceutical group GlaxoSmithKline said Wednesday that its annual performance should be better than expected, ...
GSK anticipates high sales and profit growth in 2025 after surpassing second-quarter forecasts, while addressing U.S. tariffs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback